Metabolic shift underlies recovery in reversible infantile respiratory chain deficiency

Mostra el registre complet Registre parcial de l'ítem

• dc.contributor.author Hathazi, Denisa
• dc.contributor.author Lochmüller, Hanns
• dc.contributor.author Horvath, Rita
• dc.date.accessioned 2020-11-13T07:31:02Z
• dc.date.available 2020-11-13T07:31:02Z
• dc.date.issued 2020
• dc.description.abstract Reversible infantile respiratory chain deficiency (RIRCD) is a rare mitochondrial myopathy leading to severe metabolic disturbances in infants, which recover spontaneously after 6-months of age. RIRCD is associated with the homoplasmic m.14674T>C mitochondrial DNA mutation; however, only ~ 1/100 carriers develop the disease. We studied 27 affected and 15 unaffected individuals from 19 families and found additional heterozygous mutations in nuclear genes interacting with mt-tRNAGlu including EARS2 and TRMU in the majority of affected individuals, but not in healthy carriers of m.14674T>C, supporting a digenic inheritance. Our transcriptomic and proteomic analysis of patient muscle suggests a stepwise mechanism where first, the integrated stress response associated with increased FGF21 and GDF15 expression enhances the metabolism modulated by serine biosynthesis, one carbon metabolism, TCA lipid oxidation and amino acid availability, while in the second step mTOR activation leads to increased mitochondrial biogenesis. Our data suggest that the spontaneous recovery in infants with digenic mutations may be modulated by the above described changes. Similar mechanisms may explain the variable penetrance and tissue specificity of other mtDNA mutations and highlight the potential role of amino acids in improving mitochondrial disease.
• dc.description.sponsorship RH was supported by the European Research Council [309548], the Wellcome Investigator Award [109915/Z/15/Z]. the Medical Research Council (UK) [MR/N025431/1]; the Wellcome Trust Pathfinder Scheme [201064/Z/16/Z], the Newton Fund [UK/Turkey, MR/N027302/1], the Lily Foundation and the Evelyn Trust.
• dc.format.mimetype application/pdf
• dc.identifier.citation Hathazi D, Griffin H, Jennings MJ, Giunta M, Powell C, Pearce SF et al. Metabolic shift underlies recovery in reversible infantile respiratory chain deficiency. EMBO J. 2020 Dec 1;39(23):e105364. DOI: 10.15252/embj.2020105364
• dc.identifier.doi http://dx.doi.org/10.15252/embj.2020105364
• dc.identifier.issn 0261-4189
• dc.identifier.uri http://hdl.handle.net/10230/45751
• dc.language.iso eng
• dc.publisher EMBO Press
• dc.relation.ispartof EMBO J. 2020 Dec 1;39(23):e105364
• dc.relation.projectID info:eu-repo/grantAgreement/EC/FP7/309548
• dc.rights © 2020 The Authors Published under the terms of the CC BY 4.0 license (http://creativecommons.org/licenses/by/4.0/). This is an open access article under the terms of the Creative Commons Attribution 4.0 License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
• dc.rights.accessRights info:eu-repo/semantics/openAccess
• dc.rights.uri http://creativecommons.org/licenses/by/4.0/
• dc.subject.keyword Digenic inheritance
• dc.subject.keyword Homoplasmic tRNA mutation
• dc.subject.keyword Mitochondrial myopathy
• dc.subject.keyword Reversible infantile respiratory chain deficiency
• dc.title Metabolic shift underlies recovery in reversible infantile respiratory chain deficiency
• dc.type info:eu-repo/semantics/article
• dc.type.version info:eu-repo/semantics/publishedVersion